Ziprasidone, Diazepam, or the Combination for Prevention of Cocaine Toxicity in a Mouse Model

Academic Emergency Medicine

Volumn 14, Issue 8, 2007, Pages 691-694

  Cleveland, Nathan R ^a   Krier, Shay ^a   Heard, Kennon ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

cocaine; diazepam; ziprasidone

Indexed keywords

COCAINE; DIAZEPAM; PLACEBO; ZIPRASIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; LETHAL DOSE; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SEIZURE; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CONFIDENCE INTERVALS; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; MALE; MICE; MICE, INBRED STRAINS; PIPERAZINES; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; THIAZOLES;

EID: 34447529056     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2007.04.012     Document Type: Article

References (15)

1. United States Office of Applied Statistics. Cocaine, pain killers, marijuana: marijuana, cocaine, pain killers estimates by state treatment areas, 2006. Available at http://www.oas.samhsa.gov/subState2k6/cocaine.htm#Tab. Accessed Jan 31, 2007.
2. Tseng C.C., Derlet R.W., and Albertson T.E. Acute cocaine toxicity: the effect of agents in non-seizure-induced death. Pharmacol Biochem Behav 46 (1993) 61-65
3. American Heart Association. Part 10.2: toxicology in ECC. Circulation 112 (2005) IV126-IV132
4. Cleveland N.J., Dewitt C.D., and Heard K. Ziprasidone pretreatment attenuates the lethal effects of cocaine in a mouse model. Acad Emerg Med 12 (2005) 385-388
5. United States Food and Drug Administration. Guidance for Industry and Reviewers, 2002. Available at: http://www.fda.gov/cber/gdlns/dose.pdf. Accessed Mar 31, 2007.
6. Derlet R.W., Albertson T.E., and Rice P. Antagonism of cocaine, amphetamine, and methamphetamine toxicity. Pharmacol Biochem Behav 36 (1990) 745-749
7. Schmidt A.W., Lebel L.A., Howard Jr. H.R., and Zorn S.H. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 425 (2001) 197-201
8. Seeger T.F., Seymour P.A., Schmidt A., et al. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther 275 (1995) 101-113
9. Tatsumi M., Jansen K., Blakely R.D., and Richelson E. Pharmacological profile of neuroleptics at human monoamine transporters. Eur J Pharmacol 368 (1999) 277-283
10. Ritz M.C., and George F.R. Cocaine toxicity: concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality. Psychopharmacology (Berl) 129 (1997) 311-321
11. Ritz M.C., and George F.R. Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors. Psychopharmacology (Berl) 129 (1997) 299-310
12. Ritz M.C., and George F.R. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J Pharmacol Exp Ther 264 (1993) 1333-1343
13. Martel M., Sterzinger A., Miner J., Clinton J., and Biros M. Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam. Acad Emerg Med 12 (2005) 1167-1172
14. Citrome L., Brook S., Warrington L., Loebel A., and Mandel F.S. Ziprasidone versus haloperidol for the treatment of agitation. [abstract]. Ann Emerg Med 44 (2004) S22
15. Francis A., Preval H., Klotz S.G., and Southard R. Intramuscular ziprasidone in the psychiatric emergency department: expanded sample. [abstract]. Ann Emerg Med 44 (2004) S22-S23